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Abstract
 
Innate immune responses to pathogens critically impact the development of adaptive immune
responses. However, it is not completely understood how innate immunity controls the initia-
tion of adaptive immunities or how it determines which type of adaptive immunity will be in-
duced to eliminate a given pathogen. Here we show that viral stimulation not only triggers nat-
ural interferon (IFN)-
 
a
 
/
 
b
 
–producing cells (IPCs) to produce vast amounts of antiviral IFN-
 
a
 
/
 
b
 
but also induces these cells to differentiate into dendritic cells (DCs). IFN-
 
a
 
/
 
b
 
 and tumor
necrosis factor 
 
a
 
 produced by virus-activated IPCs act as autocrine survival and DC differenti-
ation factors, respectively. The virus-induced DCs stimulate naive CD4
 
1
 
 T cells to produce
IFN-
 
g
 
 and interleukin (IL)-10, in contrast to IL-3–induced DCs, which stimulate naive CD4
 
1
 
T cells to produce T helper type 2 cytokines IL-4, IL-5, and IL-10. Thus, IPCs may play two
master roles in antiviral immune responses: directly inhibiting viral replication by producing
large amounts of IFN-
 
a
 
/
 
b
 
, and subsequently triggering adaptive T cell–mediated immunity by
differentiating into DCs. IPCs constitute a critical link between innate and adaptive immunity.
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Introduction
 
Innate immunity has two functions: (i) directly killing
pathogens and (ii) determining the initiation and type of
adaptive immune responses (1, 2). In most cases, cells in the
innate immune system indirectly perform the second func-
tion by inducing maturation of dendritic cells (DCs)
 
1
 
 with
proinflammatory cytokines such as IL-1 and TNF-
 
a
 
 (3–5).
The mature DCs then initiate adaptive immune responses
by strongly activating antigen-specific naive T cells (6) and
may also dictate the type of Th cell response to be Th1 or
Th2 (7–10). Thus, different cell types in the immune sys-
tem are specialized to perform a particular function and co-
operate to create the whole immune response.
IFN-
 
a
 
/
 
b
 
 plays an essential role in antiviral innate immu-
nity (11) by directly inhibiting viral replication in infected
cells (12). Recent studies have shown that CD4
 
1
 
CD11c
 
2
 
type 2 DC precursors (pre-DC2s) in human blood are
identical to natural IFN-
 
a
 
/
 
b
 
–producing cells (IPCs),
which produce enormous amounts of IFN-
 
a
 
/
 
b
 
 in response
to viruses (13–15). Thus, IPCs/pre-DC2s may represent a
crucial effector cell type in antiviral innate immunity. In-
terestingly, unlike other effector cell types in the innate im-
mune system such as neutrophils, macrophages, and mast
cells, IPCs have the potential to differentiate into DCs
when cultured with IL-3 and CD40 ligand (16). However,
these factors, mainly derived from activated T cells, may
not represent the earliest physiological signals for DC dif-
ferentiation in antiviral immune responses. Therefore, we
asked (i) whether viruses can directly induce IPCs to differ-
entiate into DCs after triggering the antiviral innate effector
function of IPCs and (ii) what kind of T cell responses vi-
rus-induced DCs would initiate.
 
Materials and Methods
 
Isolation and Culture of Cells.
 
Monocytes, CD11c
 
1
 
 DCs, and
IPCs were isolated from human peripheral blood as described (3,
16). To isolate monocytes, total PBMCs were centrifuged on
52% Percoll (Amersham Pharmacia Biotech). The low-density
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cells were depleted of lymphocytes with a mixture of anti-CD2,
anti-CD3, anti-CD8, anti-CD19, anti-CD20, and anti-CD56
mAbs and with magnetic beads coated with goat anti–mouse IgG
(Dynabeads M-450; Dynal). To isolate CD11c
 
1
 
 DCs and IPCs,
total PBMCs were depleted of lymphocytes and monocytes with
a mixture of anti-CD3, anti-CD14, anti-CD16, anti-CD19, and
anti-CD56 mAbs and with magnetic beads (Dynal).
CD4
 
1
 
CD11c
 
1
 
lin
 
2
 
 cells and CD4
 
1
 
CD11c
 
2
 
lin
 
2
 
 cells were iso-
lated as CD11c
 
1
 
 DCs and IPCs, respectively, by cell sorting. The
cells were cultured in RPMI 1640 containing 10% FCS at 2 
 
3
 
10
 
4
 
 cells per 200 
 
m
 
l in round-bottomed 96-well culture plates in
the presence of 10
 
6
 
 PFU/ml HSV-1 (KOS strain) attenuated with
gamma irradiation or 10
 
6
 
 PFU/ml intact influenza virus (PR8
strain). The concentrations of viruses that induced optimal sur-
vival and IFN production were selected. Higher concentrations
of viruses induced cell death, probably due to an overwhelming
cytopathic effect (data not shown).
 
Flow Cytometric Analysis.
 
IPCs were cultured for 3 d with 10
 
6
 
PFU/ml HSV, 10 ng/ml IL-3 (R&D Systems), 500 IU/ml IFN-
 
a
 
2b
 
 (Schering-Plough), 10 ng/ml TNF-
 
a
 
 (R&D Systems), 10
ng/ml IL-6 (DNAX), 20 
 
m
 
g/ml mouse anti–human TNF-
 
a
 
mAb (MP9-20A4; a gift from J. Abrams, DNAX), or 20 
 
m
 
g/ml
mouse anti–human IL-6 mAb (MQ2-39C3; DNAX). The re-
sulting cells were stained with FITC-conjugated anti–HLA-
A,B,C (G46-2.6; PharMingen), FITC-conjugated anti–HLA-
DR (L243; Becton Dickinson), PE-conjugated anti-CD80
(L307.4; Becton Dickinson), PE-conjugated anti-CD86 (2331;
PharMingen), or an isotype control Ab and were analyzed with a
FACScan™ flow cytometer (Becton Dickinson). Dead cells were
excluded by staining with propidium iodide.
 
T Cell Proliferation Assay.
 
Naive CD4
 
1
 
 T cells were isolated
from umbilical cord blood (Advanced Bioscience Technologies)
using a CD4 Positive Isolation Kit (Dynal). 5 
 
3
 
 10
 
4
 
 naive CD4
 
1
 
T cells were cocultured with fresh IPCs, HSV-induced DCs
(HSV-DCs), or IL-3–induced DCs (IL-3–DCs) in round-bot-
tomed 96-well culture plates in Yssel’s medium (Irvine Scientific)
containing 10% FCS. After 5 d, cells were pulsed with 1 
 
m
 
Ci
[
 
3
 
H]thymidine (Amersham Pharmacia Biotech) for 16 h before
harvesting.
 
DC–T Cell Coculture for Cytokine Assays.
 
5 
 
3
 
 10
 
4
 
 allogeneic
naive CD4
 
1
 
 T cells were cocultured with 10
 
4
 
 DCs for 6 d in
round-bottomed 96-well culture plates in Yssel’s medium con-
taining 10% FCS. In some experiments, 10 
 
m
 
g/ml neutralizing
mouse anti–human IL-12 mAb C.8.6.22 (17) and/or a mixture
of 1,000 neutralization U/ml rabbit anti–human IFN-
 
a
 
 Ab
(PBL), 2,000 neutralization U/ml rabbit anti–human IFN-
 
b
 
 Ab
(PBL), and 10 
 
m
 
g/ml mouse anti–human IFN-
 
a
 
/
 
b
 
 receptor
mAb IFNaR
 
b
 
1 (18) was added during the coculture. Alterna-
tively, T cells were cultured for 6 d with plate-bound anti-CD3
mAb SPV-T3b (19) and 1 
 
m
 
g/ml soluble anti-CD28 mAb
Figure 1. HSV induces differ-
entiation of IPCs into DCs. (A)
Cell numbers of IPCs cultured in
different conditions. Viable cells
were counted by trypan blue ex-
clusion. The data shown are rep-
resentative of three experiments.
(B) Phenotype of fresh IPCs,
HSV-stimulated IPCs, and IL-3–
stimulated IPCs. Open histo-
grams represent cells stained with
isotype-matched control mAbs.
The data shown are representa-
tive of four experiments. (C) Al-
logeneic mixed lymphocyte re-
action. Naive CD41 T cells from
cord blood were cocultured with
different numbers of fresh IPCs,
HSV-DCs, or IL-3–DCs for 6 d.
Error bars indicate SD. The data
shown are representative of five
experiments. 
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L293.1 (Becton Dickinson). After 6 d of priming, T cells were
washed and restimulated at 10
 
6 
 
cells/ml with anti-CD3 and anti-
CD28 for 24 h for ELISA or for 5 h for intracellular cytokine
staining. 10 
 
m
 
g/ml brefeldin A (Epicentre Technologies) was
added at 2.5 h for intracellular staining.
 
Quantitation of Cytokine Secretion by ELISA.
 
ELISA kits from
the following companies were used to analyze cytokine produc-
tion: IFN-
 
a
 
 (Biosource International), IFN-
 
b
 
 (FUJIREBIO), IL-
18 (MBL Medical and Biological Lab. Co.), IL-1
 
a
 
, IL-1
 
b
 
, IL-2,
IL-3, IL-4, IL-5, IL-10, IL-12, IL-15, IFN-
 
g
 
, lymphotoxin 
 
a
 
,
and GM-CSF (R&D Systems).
 
Flow Cytometric Analysis of Intracellular Cytokines.
 
Intracellu-
lar cytokines produced by T cells were analyzed as described (8).
 
Results
 
Viruses Directly Induce IPCs to Differentiate into DCs.
 
We and others previously showed that IPCs die rapidly and
that few viable cells are found after 3 d of culture in me-
dium alone (reference 16, 20, 21; Fig. 1 A). However,
 
z
 
50% of the initial numbers of the cells were viable after
3 d of culture with either HSV or IL-3. IPCs differentiate
into immature DC2s when cultured with IL-3 (16). Simi-
larly, IPCs acquired DC morphology after 3 d of culture
with HSV (data not shown). They also increased the ex-
pression of MHC class I and class II antigens as well as co-
stimulatory molecules CD80 and CD86 (Fig. 1 B). IPCs
stimulated with HSV for 3 d (HSV-DCs) were as potent as
IPCs stimulated with IL-3 for 3 d (IL-3–DCs) in inducing
proliferation of allogeneic naive CD4
 
1
 
 T cells (Fig. 1 C).
Influenza virus also induced IPCs to differentiate into DCs
(data not shown). These data demonstrate that viruses can
 
directly induce differentiation of the DC precursors into
DCs in the absence of exogenous cytokines.
 
IFN-
 
a
 
/
 
b
 
 and TNF-
 
a
 
 Function as Autocrine Survival and
Differentiation Factors of IPCs, Respectively.
 
Next we tested
whether endogenous cytokines from IPCs induced by vi-
ruses are responsible for the survival and differentiation of
the cells. Consistent with previous reports (14, 15), IPCs
produced large amounts of IFN-
 
a
 
 and IFN-
 
b
 
 within 24 h
in response to HSV, whereas monocytes and CD11c
 
1
 
 DCs
produced only small or undetectable amounts (Fig. 2).
IPCs also produced significant amounts of TNF-
 
a
 
 and IL-6
(Fig. 2), but IL-1
 
a
 
, IL-1
 
b
 
, IL-3, IL-10, IL-12, IL-15, IL-
18, IFN-
 
g
 
, lymphotoxin 
 
a
 
, and GM-CSF were undetect-
able (data not shown). IFN-
 
a
 
, but not TNF-
 
a
 
 (Fig. 3 A)
or IL-6 (data not shown), was found to maintain the sur-
vival of IPCs during 3 d of culture, suggesting that IFN-
 
a
 
is a virus-induced autocrine survival factor for IPCs. IFN-
 
a
 
did not upregulate CD80 and CD86 on IPCs (Fig. 3 B).
However, TNF-
 
a
 
 was found to upregulate CD86 and to a
lesser extent CD80 on IPCs when added with IFN-
 
a
 
 (Fig.
3 B). Anti–TNF-
 
a
 
 diminished the expression of CD80 and
CD86 on HSV-stimulated IPCs (data not shown). On the
other hand, IL-6 or anti–IL-6 did not affect the expression
of CD80 and CD86 (data not shown). Thus, IFN-a/b and
TNF-a may represent virus-induced autocrine survival fac-
tors and a partial differentiation factor, respectively, for
IPCs to become DCs.
IL-3–DCs and HSV-DCs Induce Distinct T Cell Differenti-
ation. To examine the role of HSV-DCs in naive T
helper cell differentiation, allogeneic naive CD41 T cells
were cultured for 6 d with IL-3–DCs, HSV-DCs, or anti-
Figure 2. Cytokine produc-
tion by different populations of
blood cells stimulated with HSV.
Cells were stimulated with HSV
for 24 h, and cytokine concen-
trations in the supernatants were
measured by ELISA. PBMC,
total PBMCs; Mono, mono-
cytes; CD11c1 DC, FACS-
sorted CD11c1lin2 immature
DCs; IPC, FACS®-sorted CD41
CD11c2lin2 cells. Error bars in-
dicate SD. The data shown are
representative of four experi-
ments.222 Natural Interferon a/b–producing Cells
CD3 and anti-CD28. The activated T cells were restimu-
lated with anti-CD3 and anti-CD28 for either 5 h for in-
tracellular cytokine staining or 24 h for cytokine ELISA of
the culture supernatants. Whereas IL-3–DCs induced naive
CD41 T cells to produce high levels of IL-4, IL-5, and IL-
10 and a low level of IFN-g as reported (8), HSV-DCs in-
duced naive CD41 T cells to produce high levels of IFN-g
and IL-10 and a low level of IL-4 (Fig. 4 A). Intracellular
cytokine staining showed that HSV-DCs induced CD41 T
cells to differentiate into three subpopulations with respect
to IFN-g and IL-10 expression: (i) IFN-g1IL-102, (ii)
IFN-g2IL-101, and (iii) IFN-g1IL-101 (Fig. 4 B). IL-12
(22) and IFN-a (de Waal Malefyt, R., personal communi-
cation and reference 23) were shown to induce T cells to
produce IFN-g and IL-10. However, IPCs did not pro-
duce a detectable level of IL-12 during 3 d of culture with
HSV (data not shown), and anti–IL-12 mAb did not inhibit
IFN-g or IL-10 production by T cells cultured with HSV-
DCs (Fig. 4 C), suggesting that IL-12 is not involved in
IFN-g and IL-10 induction in this system. A mixture of
anti-IFN-a, anti-IFN-b, and anti-IFN-a/b receptor Abs
significantly diminished the induction of IFN-g but not
IL-10 in the T cell–HSV-DC coculture (Fig. 4 C), indicat-
ing that IFN-a/b from HSV-DCs is responsible for T cell
production of IFN-g but not IL-10. HSV-DCs may stimu-
late T cells to produce a high level of IL-10 by an IL-12–
and IFN-a/b–independent mechanism.
Discussion
DC precursors develop into mature DCs in two steps:
first, differentiation into immature DCs, and second, devel-
opment from immature into mature DCs (6). Recent stud-
ies have shown that whereas microbial stimuli trigger the
final maturation of DCs (24), differentiation of DC precur-
sors into immature DCs is dependent on cytokines such as
GM-CSF, TNF-a, and IL-4 (3, 25, 26). However, the
physiological relevance of these cytokines in DC differenti-
ation in vivo remains to be established (27). Our study
demonstrated that viral stimulation alone is capable of in-
ducing DC precursors to differentiate into DCs in the ab-
sence of exogenous cytokines. This, together with the abil-
ity of monocytes to differentiate into DCs after undergoing
transendothelial migration and phagocytosis (28, 29), sug-
gests that microbes, as well as cytokines, may directly trig-
ger differentiation of DC precursors into DCs.
The finding that IL-3–DCs and HSV-DCs induce dis-
tinct types of T cell differentiation illustrates the critical
role of innate immunity in determining the type of adap-
tive immune responses, depending on the nature of patho-
gens (30). Upon invasion of certain parasites or allergens,
IL-3 produced by activated mast cells (31) may cause IPCs
to differentiate into Th2-inducing DCs, which may con-
tribute to the establishment of T cell–mediated allergic re-
sponses. On the other hand, HSV-DCs induce naive
CD41 T cells to produce IFN-g and IL-10, different from
a classical Th1 or Th2 type. Existence of a T cell popula-
tion producing IFN-g and IL-10 during intracellular infec-
tion with viruses (32), bacteria (33), and parasites (34) sug-
gests that IFN-g– and IL-10–producing T cells may play an
important role in immune responses to intracellular patho-
Figure 3. IFN-a and TNF-a function as autocrine survival and differ-
entiation factors of IPCs, respectively. (A) Cell numbers of IPCs cultured
without stimulation or with HSV, IFN-a, or TNF-a. Viable cells were
counted by trypan blue exclusion. The data shown are representative of
three experiments. (B) Expression of CD80 and CD86 on fresh IPCs and
IPCs cultured with IFN-a, IFN-a and TNF-a, or HSV for 3 d. Few
cells remained viable in culture with TNF-a alone, as shown in A. Open
histograms represent cells stained with isotype-matched control mAbs.
The data shown are representative of four experiments.223 Kadowaki et al.
gens. In fact, it has been suggested that IL-10 protects the
host against detrimental effects of excessive cellular im-
mune responses elicited during acute infection (35).
This study, together with previous studies (8, 14, 15), in-
dicates that IPCs represent a unique cell lineage within the
immune system, which performs the two master functions
of innate immunity during their lifetime: (i) killing of vi-
ruses and (ii) initiation and dictation of adaptive immune
responses. Importantly, the functional transition from IPCs
to DCs occurs with viral stimulation alone in the absence
of any exogenous factors. In addition to viruses, bacterial
stimuli such as heat-killed Staphylococcus aureus also induce
IPCs to produce large amounts of IFN-a/b (36) and to
upregulate CD80 and CD86 (data not shown). These find-
ings, together with pleiotropic effects of IFN-a/b on vari-
ous cell types in the immune system such as macrophages
(37), NK cells (38), and T cells (39–41), suggest that IPCs
represent a crucial cell type in the immune system that,
upon recognizing various types of pathogens, promptly
alerts the immune system to “dangers” (42) by producing
vast amounts of IFN-a/b and subsequently initiates adap-
tive immune responses by differentiating into DCs. Fur-
thermore, IPCs may be involved in allergic responses by
differentiating into Th2-inducing DCs in response to IL-3.
This marked versatility of IPCs distinguishes them from
other cell types in the immune system that have only lim-
ited functions and suggests that IPCs may play a key role in
integrating the innate and adaptive aspects of various im-
mune responses.
In conclusion, this study offers an account of the cellular
and molecular mechanisms by which innate immunity
connects with and shapes adaptive immunity. Owing to the
Figure 4. IL-3–DCs and HSV-DCs induce different types of differentiation of naive CD41 T cells. Allogeneic naive CD41 T cells were cultured for
6 d with IL-3–DCs, HSV-DCs, or anti-CD3 and anti-CD28. T cells were restimulated with anti-CD3 and anti-CD28 for 24 h (A) or 48 h (C) for
ELISA or for 5 h for intracellular staining (B). (A) Quantitation of IFN-g, IL-4, IL-5, and IL-10 by ELISA. Error bars indicate SD. The data shown are
representative of four experiments. (B) Intracellular IFN-g, IL-4, and IL-10 staining of T cells cultured with HSV-DCs. The percentages in each quad-
rant are indicated on the plot. The data shown are representative of three experiments. (C) IFN-g and IL-10 production by T cells cultured with HSV-
DCs in the presence of neutralizing anti–IL-12 mAb and/or a mixture of anti–IFN-a, anti–IFN-b, and IFN-a/b receptor Abs. The same concentration
of anti–IL-12 mAb inhibited IFN-g production by T cells cultured with anti-CD3, anti-CD28, and 10 ng/ml IL-12 (data not shown). Error bars indicate
SD. The data shown are representative of three experiments.224 Natural Interferon a/b–producing Cells
apparent involvement of IPCs in a variety of immune re-
sponses, enhancing or suppressing functions of these cells
may serve as potential therapies for infectious diseases, can-
cers, and allergic diseases.
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